Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorder.

Scientific reports - 14 May 2026

McEvoy Alannah, Rodrigues Myanca, Hudson Jacqueline, Marsh David C, Thabane Lehana, Samaan Zainab

Abstract excerpt

Opioid Use Disorder (OUD) is a chronic condition for which Medications for Opioid Use Disorder (MOUD) are crucial. Methadone Maintenance Treatment (MMT) and buprenorphine/naloxone (BN) are MOUD used to decrease opioid cravings and use, however, retention rates for MMT and BN vary. Genetic factors associated with retention in patients with other MOUD are largely unknown. The objective was to investigate the role...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methadone

Share to Opioid-Related Disorders

Share to Polymorphism, Single Nucleotide

Share to Receptors, Opioid, delta

Source

Open in PubMed Open full text

Identifiers

PMID: 42135448
DOI: 10.1038/s41598-026-52706-1
PMCID: PMC13365242

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association between the T allele in rs204076 and treatment retention in patients receiving medication for opioid use disorder.PMID 42135448Read ↗

Genetic Associations of Persistent Opioid Use After Surgery Point to OPRM1 but Not Other Opioid-Related Loci as the Main Driver of Opioid Use Disorder.Semantic proximity Read ↗

Association of OPRM1 Functional Coding Variant With Opioid Use DisorderSemantic proximity Read ↗

OPRM1 rs1799971 Polymorphism Predicts Differential Response to Extended-Release Naltrexone in Alcohol Use Disorder: The Interplay of Genetics and Motivation.Semantic proximity Read ↗

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.Semantic proximity Read ↗

The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.Semantic proximity Read ↗

Genetic associations of persistent opioid use after surgery: a hypothesis-driven analysis of high-value genetic variants in the Michigan Genomics Initiative datasetSemantic proximity Read ↗

A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.Semantic proximity Read ↗

Buprenorphine treatment of opioid dependence: analysis of individual patient dataSemantic proximity Read ↗

The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.Semantic proximity Read ↗

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.Semantic proximity Read ↗

Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.Semantic proximity Read ↗

Outcome in methadone maintenance treatment of immigrants from the former Union of Soviet Socialist RepublicsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.